Latest News

In the last 2 hours
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane® PR Newswire (Press Release)10:21
In the last 7 days
Sanofi: AI Is Helping Us Make Big Calls On Drug Development Scrip Pharma Intelligence12:27 8-Dec-23
UBS maintains neutral rating on Sanofi with €100 target price Investing.com11:58 8-Dec-23
Kymera’s protein degrader starts Phase II trial in atopic dermatitis Clinical Trials Arena11:05 8-Dec-23
Eligo Bioscience secures $30M Series B for its microbiome gene-editing technology Tech.eu10:39 8-Dec-23
Sanofi’s Phase III multiple myeloma trial meets primary goal Clinical Trials Arena06:10 8-Dec-23
Three phase IIIs: BMS, Merck and Sanofi release new cancer data BioWorld17:18 7-Dec-23
Sanofi (SNY) Posts Upbeat Long-Term Outlook, Enhances R&D Focus Zacks14:30 7-Dec-23
Sanofi Tries To Win Skeptics Over To Its Immunology Masterplan Scrip Pharma Intelligence13:13 7-Dec-23
Kymera Therapeutics Announces First Patient Dosed in Phase 2 Atopic Dermatitis Clinical Trial of KT-474 (SAR444656), a… BioSpace11:41 7-Dec-23
Sanofi's quiet Sarclisa chalks up a first-in-class win with eyes on a first-line multiple… FiercePharma11:35 7-Dec-23
Sanofi R&D day: CEO Paul Hudson touts 12 blockbusters, ups R&D spend ENDPOINTS10:59 7-Dec-23
Sanofi makes $140m deal for AI drug discovery Verdict Medical Devices10:40 7-Dec-23
Sanofi hails potential $1 billion-a-year drug candidates Reuters - YouTube10:20 7-Dec-23
Sanofi Touts 12 Potential Blockbusters in Bid to Regain Investor Confidence BioSpace09:38 7-Dec-23
STAT Plus: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi… STAT09:11 7-Dec-23
Sanofi to boost drug development spend by 700 mln euros in 2024 Reuters08:25 7-Dec-23
Sanofi Lays Out Ambitious Plans To Bolster Its Pipeline, Highlights 12 Blockbuster Opportunities Benzinga07:41 7-Dec-23
Sanofi, facing skeptical investors, predicts $5B sales for 3 drugs, names 9 more blockbusters FierceBiotech06:53 7-Dec-23
Sanofi says new drugs can add €10bn to sales by 2030 pharmaphorum05:37 7-Dec-23
Sanofi: Sarclisa Phase 3 Trial Meets Primary Endpoint Of Progression Free Survival RTT News03:52 7-Dec-23
Sanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage Trial MarketWatch02:06 7-Dec-23
Sanofi Sees Annual Sales From New Pharma Assets Above $10.8 Bln by 2030 MarketWatch01:56 7-Dec-23
Sanofi Says Pharma Sales Set to Reach €10 Billion by 2030 BNN Bloomberg23:33 6-Dec-23
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline Reuters22:44 6-Dec-23
Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster… GlobeNewswire (Press Release)21:36 6-Dec-23
STAT Plus: Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it? STAT21:36 6-Dec-23
Merck KGaA’s experimental MS drug fails in late stage trials Proactive Investors (Canada)11:51 6-Dec-23
After Sanofi, GSK, another consumer giant moves to dissolve operations in Nigeri... Legit NG10:30 6-Dec-23
Sanofi and AI specialist Aqemia enter $140m drug discovery partnership PMLiVE07:49 6-Dec-23
Sanofi offers Aqemia up to $140m to find new drugs with AI Silicon Republic06:07 6-Dec-23
Sanofi expands genAI drug discovery pact with Aqemia pharmaphorum04:32 6-Dec-23
Regulator OKs Sanofi Korea's high-dose influenza vaccine for seniors Korea Biomedical Review23:52 5-Dec-23
Raquel Erb Excels as AMCP Foundation Intern PR Newswire (Press Release)11:52 5-Dec-23
Sanofi signs $140m small molecule discovery deal with Aqemia Pharmaceutical Technology11:05 5-Dec-23
Novartis follows Pfizer, GSK, J&J and Sanofi as it launches a fresh corporate rebranding FiercePharma08:33 5-Dec-23
Sanofi spins up AI pact, inking $140M deal to apply Aqemia’s physics algorithms to drug… FierceBiotech07:38 5-Dec-23
Sanofi offers up to $140M in new collaboration with Aqemia Tech.eu07:28 5-Dec-23
Sanofi Shares in Spotlight Ahead of Investor Day TipRanks06:36 5-Dec-23
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines Business Wire (Press Release)06:05 5-Dec-23
Sanofi Strikes $140 Million Drug-Research Deal With Aqemia BNN Bloomberg05:38 5-Dec-23
Sanofi’s AI dealmaking continues with up to $140M for collaboration with Paris startup Aqemia ENDPOINTS02:02 5-Dec-23
AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi Business Wire (Press Release)02:00 5-Dec-23
Sanofi CEO under pressure to woo investors after spending shock Reuters01:16 5-Dec-23
Analysis-Sanofi CEO under pressure to woo investors after spending shock Investing.com UK01:11 5-Dec-23
SAR-445399 by Sanofi for Inflammation: Likelihood of Approval Pharmaceutical Technology01:03 5-Dec-23
Constellation Appoints Sanofi Veteran Bill Berry as New General Manager of Life Sciences and… PR Newswire (Press Release)09:07 4-Dec-23
Latex Allergy Market May See a Big Move| Alcon Vision, Novartis, Sanofi Industry Today05:43 4-Dec-23
Bosch, Sanofi India, Eicher Motors, Grasim Industries and Lupin among 278 stocks that hit 52-week high; 12 touch… The Financial Express04:13 4-Dec-23
How government policies are killing businesses, forcing industries to shut down —Experts Tribune Online07:07 3-Dec-23
In the last month
Atopic Dermatitis Market to grow significantly by 2032 | Sanofi, Regeneron Pharmaceuticals,… Industry Today04:03 2-Dec-23
Pharma Heads Pass Leadership Baton BioSpectrum Asia23:59 1-Dec-23
J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey FiercePharma11:13 1-Dec-23
Teva and Sanofi conclude collaboration deal for anti-TL1A therapy Pharmaceutical Technology05:10 1-Dec-23
Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to… Sanofi (Press Release)02:09 1-Dec-23
After GSK, Sanofi, another foreign company to leave Nigeria, sells shares to loc... Legit NG11:36 30-Nov-23
Teva Closes Collaboration Deal With Sanofi on IBD Treatment MarketWatch08:58 30-Nov-23
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease… Business Wire (Press Release)08:32 30-Nov-23
Pharma boss: EU’s open strategic autonomy needs a European health security act EurActiv.com01:18 30-Nov-23
White House, Sanofi and AZ take steps to head off RSV antibody shortage for 2024-25 virus season FiercePharma11:16 29-Nov-23
White House urges RSV vaccine makers to meet demand Yahoo! US10:48 28-Nov-23
Sanofi: A Shift In The Story Seeking Alpha01:28 28-Nov-23
Dupixent Heralds The Age Of Biologics In COPD Scrip Pharma Intelligence18:31 27-Nov-23
Another ‘homerun’ for Dupixent as Sanofi, Regeneron plan year-end filing in COPD BioWorld17:06 27-Nov-23
Local Virginia governments add to insulin lawsuits against Eli Lilly, Novo Nordisk, Sanofi, others ENDPOINTS15:02 27-Nov-23
How the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more… Fortune14:39 27-Nov-23
Regeneron, Sanofi to seek new Dupixent approval in US after COPD success BioPharma Dive12:07 27-Nov-23
Prescription: Beyfortus From Sanofi Pasteur, Inc Pharmacy Times11:44 27-Nov-23
On a roll, Sanofi and Regeneron's Dupixent scores again in second COPD trial FiercePharma10:56 27-Nov-23
Regeneron and Sanofi Find Further Positive Results for Dupixent in COPD BioSpace10:45 27-Nov-23
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales Investors Business Daily10:35 27-Nov-23
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study Zacks10:06 27-Nov-23
Sanofi to accelerate ‘smokers lung’ treatment after phase 3 trial success Biopharma Reporter09:46 27-Nov-23
STAT Plus: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s… STAT09:23 27-Nov-23
Sanofi and Regeneron’s Dupixent scores second win in Phase III COPD trial Pharmaceutical Technology08:18 27-Nov-23
Sanofi/Regeneron’s Dupixent shows promise in chronic obstructive pulmonary disease PMLiVE07:27 27-Nov-23
Dupixent aces second COPD study, setting up FDA filing pharmaphorum07:07 27-Nov-23
Aeglea rebrands to Spyre, names new CEO in IBD race against TL1A drugs at Merck, Roche and Sanofi ENDPOINTS07:03 27-Nov-23
Breakthrough in COPD treatment European Biotechnology News06:51 27-Nov-23
Sanofi and Regeneron set to file for FDA approval of Dupixent for COPD Investing.com06:02 27-Nov-23
Sanofi shares results from phase 3 trial for Dupixent as COPD treatment Pharmafile05:47 27-Nov-23
Sanofi Says Notus Phase 3 Trial of Dupixent Met Primary Endpoint MarketWatch02:16 27-Nov-23
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial BNN Bloomberg02:01 27-Nov-23
Sanofi looks to widen Dupixent use to treat 'smoker's lung' after second trial win Reuters01:44 27-Nov-23
Dupixent succeeds in another late-stage COPD study, Sanofi and Regeneron say, setting up filing for FDA approval ENDPOINTS01:39 27-Nov-23
STAT Plus: With new trial data, a blockbuster therapy from Sanofi, Regeneron could find an even … STAT01:39 27-Nov-23
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA… GlobeNewswire (Press Release)01:34 27-Nov-23
Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA… Regeneron Pharmaceuticals (Press Release)01:31 27-Nov-23
Sanofi: Information concerning the total number of voting rights and shares - October 2023 GlobeNewswire (Press Release)12:04 23-Nov-23
Alkem Labs, Sanofi India, Bajaj Auto and Hero MotoCorp among 118 stocks that hit 52-week high; 12 touch 52-week low The Financial Express04:25 23-Nov-23
Cytotoxic Drug Market Is Thriving Worldwide with Roche Holding, Eli Lilly, Celgene, Sanofi Industry Today07:12 22-Nov-23
Sanofi India, Hero MotoCorp, Cipla and Sun Pharma are among 129 stocks that hit 52-week high; 12 touch 52-week low The Financial Express04:21 22-Nov-23
Improper Orange Book listings harm competition, FTC says in amicus brief to antitrust suit ENDPOINTS22:53 21-Nov-23
Chinese Language Podcast: 创新药美国获批, AI新药研发, 三季度业绩和中美峰会 Scrip Pharma Intelligence20:38 21-Nov-23
FTC Warns Of Harms In Mylan Dispute With Sanofi Law36020:24 21-Nov-23
FTC says improper Orange Book listings harm competition in amicus brief to antitrust suit ENDPOINTS13:45 21-Nov-23
With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics FiercePharma11:47 21-Nov-23
New Research Sheds Light on Mediators of Improved Outcomes in Dario Users PR Newswire (Press Release)08:30 21-Nov-23
Sanofi pays $10 million for AI-powered protein map Chemical & Engineering News19:03 20-Nov-23
Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of… FiercePharma14:14 20-Nov-23
Senate Democrats press AstraZeneca, Sanofi on RSV antibody shortage ENDPOINTS13:00 20-Nov-23
Sanofi's Icy Hot franchise takes to the court again with Shaquille O'Neal Foundation for new… FiercePharma10:09 20-Nov-23
Senators Ask Drugmakers To Explain Shortages Of RSV Drug For Infants Kaiser Health News09:09 20-Nov-23
Broker’s call: Sanofi (Buy) The Hindu Business Line08:30 20-Nov-23
Mother of autistic children lodges complaint over emissions from Sanofi's Depakine drug plant -Le Monde Reuters05:29 20-Nov-23
Risk adjusted net present value: What is the current valuation of Sanofi’s Fitusiran? Pharmaceutical Technology22:30 18-Nov-23
Tusamitamab ravtansine by Sanofi for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of… Pharmaceutical Technology14:53 18-Nov-23
Tusamitamab ravtansine by Sanofi for Endometrial Cancer: Likelihood of Approval Pharmaceutical Technology14:53 18-Nov-23
Tusamitamab ravtansine by Sanofi for Epithelial Ovarian Cancer: Likelihood of Approval Pharmaceutical Technology14:22 18-Nov-23
Tusamitamab ravtansine by Sanofi for Bladder Carcinoma: Likelihood of Approval Pharmaceutical Technology14:22 18-Nov-23
Tusamitamab ravtansine by Sanofi for Transitional Cell Carcinoma (Urothelial Cell Carcinoma):… Pharmaceutical Technology14:22 18-Nov-23
Tusamitamab ravtansine by Sanofi for Non-Small Cell Lung Cancer: Likelihood of Approval Pharmaceutical Technology14:22 18-Nov-23
SAR-443765 by Sanofi for Asthma: Likelihood of Approval Pharmaceutical Technology14:02 18-Nov-23
Tusamitamab ravtansine by Sanofi for Solid Tumor: Likelihood of Approval Pharmaceutical Technology12:51 18-Nov-23
Tusamitamab ravtansine by Sanofi for Metastatic Breast Cancer: Likelihood of Approval Pharmaceutical Technology12:41 18-Nov-23

      
            
      
    view more headlines
   
      
      
      
10 Dec 10:21
   
About our Sanofi News

Latest news on Sanofi S.A., a French multinational pharmaceutical and healthcare company headquartered in Paris, France.
Sanofi

Latest News

About our Sanofi News

Pharmaceuticals Top Stories

Business Top Stories
